China
Africa
Explore chapters and articles related to this topic
Urinary
Published in A. Sahib El-Radhi, Paediatric Symptom and Sign Sorter, 2019
Pollakiuria (from the Greek word pollakis meaning ‘many times’) or daytime frequency syndrome of childhood, often occurs as a result of stress-related problems, including anxiety, but without dysuria or systemic disease. There is sudden onset of frequent voiding every 5–10 minutes, in a previously toilet-trained child. It often disappears suddenly in 2–3 months. Typical age of occurrence is 4–6 years.
Urinary
Published in A Sahib El-Radhi, James Carroll, Paediatric Symptom Sorter, 2017
A Sahib El-Radhi, James Carroll
Pollakiuria (from the Greek word ‘pollakis’ meaning many times) or daytime frequency syndrome of childhood, often occurs as a result of stress-related problems, e.g. anxiety. It is not associated with dysuria or systemic disease. Typical age of occurrence is 4–6 years.
Syringomyelia and lower urinary tract dysfunction
Published in Jacques Corcos, David Ginsberg, Gilles Karsenty, Textbook of the Neurogenic Bladder, 2015
Marc Le Fort, Jean-Jacques Labat, Brigitte Perrouin-Verbe
The urinary signs are not specific most of the time, as they constitute a part of the sublesional syndrome syringomyelia, with an upper motor neuron bladder due to a suprasacral lesion. Their presentation is close to that of incomplete spinal cord lesions and may mimick urinary tract infection: urgency and eventually urge incontinence, pollakiuria, hesitancy, polyphasic micturition, occasional temporary urination impossibility, and even acute urine retention. Dysuria should also provoke the search for other apparent causes such as prostate hypertrophy. Urodynamic studies argue in favor of such a spinal cord lesion, showing a poorly inhibited and/or dyssynergic bladder: lasting and wave-like high contractions are evocative.
Clinical and biochemical differences between hantavirus infection and leptospirosis: a retrospective analysis of a patient series in Belgium
Published in Acta Clinica Belgica, 2020
Emma Bakelants, Willy Peetermans, Katrien Lagrou, Wouter Meersseman
All patients complained about general malaise and fever. The mean, measured body temperature was 38.9°C, within a range of 38.3°C–40.0°C. Myalgia was mentioned 13 times. Seven patients complained about a dry cough and dyspnea, another seven patients had a headache without photo- or sonophobia. Four patients vomited, six patients had loose stools without blood loss. One patient experienced dysuria and pollakisuria. Multiple symptoms could be found in one patient. Figure 1 shows the complaints per person in more detail. Clinical examination was normal in nine cases. Two patients had malleolar edemas. One patient had conjunctivitis. Three patients had a tender right hemi abdomen. Lung auscultation was abnormal in one patient, revealing basal crackles. None of them were icteric.
An evaluation of the efficacy and safety of Tofogliflozin for the treatment of type II diabetes
Published in Expert Opinion on Pharmacotherapy, 2019
Genya Aharon-Hananel, Itamar Raz
High daytime urinary frequency is a relatively common side effect of Tofogliflozin. In a 24 week study, the incidence of pollakiuria was ≥ 5% [57]. Pollakiuria was more likely to occur with Tofogliflozin in a dose-dependent manner than with a placebo (5.2%, 6.9%, and 10.3% in the Tofogliflozin 10, 20, and 40 mg treatment groups, respectively, vs. 1.8% with the placebo) [57]. In a 12 week study on Tofogliflozin, the incidence of pollakiuria was also higher in the treatment vs. placebo group [60]. However, no increase in the incidence of orthostatic hypotension was observed throughout the study period [60]. These results are consistent with the 52 week study on Tofogliflozin [58]. In conclusion, while pollakiuria is a relatively common and inconvenient side effect of Tofogliflozin, its clinical severity is very mild.
Adverse events of hyperthermic intravesical chemotherapy for non-muscle invasive bladder cancer patients
Published in Scandinavian Journal of Urology, 2021
Jacob Agerbo Thomsen, Henning Nielsen Dominiak, Maria Skydt Lindgren, Jørgen Bjerggaard Jensen
Three patients had to stop before they had completed all six induction installations. One patient stopped treatment due to pollakiuria and incontinence and two patients due to small bladder capacity. One patient stopped treatment after the second maintenance instillation, due to a systemic reaction with universal rash and edema, which required 14 days of high-dose steroid treatment. Further investigation showed that the allergic reaction was due to allergy to Pivmecillinam, administered prophylactic prior to each of the patients’ treatments, and not a result of the HIVEC treatment itself.